SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADVR:THE NEW COMPANY...WITH A NEW LIFE...AND A NEW MISSION -- Ignore unavailable to you. Want to Upgrade?


To: BARRY ALLEN who wrote (4612)11/6/1999 9:11:00 AM
From: Kingfisher  Read Replies (1) | Respond to of 4891
 
Berry, or anyone, do you happen to know why Dr. Hirschman is now referring to Reticulose as a <<new "SWITCH-TYPE" peptide nucleic acid immunomodulator>>? What do you think is expression "SWITCH-TYPE" means?

Do you think it is just another way to express the modulation or regulation of the immune system? Do you think this simply implies something very basic like being able to turn on or off the generation of certain chemokines within the body ?